Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
Titel:
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
Auteur:
Kim, Ji-Yeon Park, Kyunghee Im, Seock-Ah Jung, Kyung Hae Sohn, Joohyuk Lee, Keun Seok Kim, Jee Hyun Yang, Yaewon Park, Yeon Hee